5-109368635-A-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_014819.5(PJA2):c.1395T>A(p.Asp465Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000328 in 1,613,954 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_014819.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PJA2 | NM_014819.5 | c.1395T>A | p.Asp465Glu | missense_variant | 5/10 | ENST00000361189.7 | NP_055634.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PJA2 | ENST00000361189.7 | c.1395T>A | p.Asp465Glu | missense_variant | 5/10 | 1 | NM_014819.5 | ENSP00000354775.2 | ||
PJA2 | ENST00000361557.4 | c.1395T>A | p.Asp465Glu | missense_variant | 4/9 | 2 | ENSP00000355284.3 |
Frequencies
GnomAD3 genomes AF: 0.000191 AC: 29AN: 152102Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000147 AC: 37AN: 251408Hom.: 0 AF XY: 0.000169 AC XY: 23AN XY: 135866
GnomAD4 exome AF: 0.000342 AC: 500AN: 1461852Hom.: 0 Cov.: 30 AF XY: 0.000342 AC XY: 249AN XY: 727234
GnomAD4 genome AF: 0.000191 AC: 29AN: 152102Hom.: 0 Cov.: 32 AF XY: 0.000175 AC XY: 13AN XY: 74286
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 02, 2024 | The c.1395T>A (p.D465E) alteration is located in exon 5 (coding exon 4) of the PJA2 gene. This alteration results from a T to A substitution at nucleotide position 1395, causing the aspartic acid (D) at amino acid position 465 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at